Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $6.9750 (1.01%) ($6.9750 - $6.9750) on Thu. Sep. 14, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.11% (three month average) | RSI | 42 | Latest Price | $6.9750(1.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.4% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) UNG(88%) USO(45%) OIH(33%) MCHI(29%) PAVE(26%) | Factors Impacting BCRX price | BCRX will decline at least -1.555% in a week (0% probabilities). ARKK(-91%) GDX(-46%) SKYY(-20%) IGOV(-47%) XLRE(-36%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.555% (StdDev 3.11%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.08 | 5 Day Moving Average | $6.96(0.22%) | 10 Day Moving Average | $7(-0.36%) | 20 Day Moving Average | $7.08(-1.48%) | To recent high | -12.6% | To recent low | 4.1% | Market Cap | $1.231b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |